• 1
    Xu Z.-Q., Pupek K., Anache L., Flavin M.T. (2003) Pyranocoumarin compounds as a novel pharmacopher with anti-TB activity. US 6,670, 383 B2, 30.
  • 2
    Muthukrishnan M., Mujahid M., Yogeeswari P., Sriram D. (2011) Syntheses and biological evaluation of new triazole-spirochromone conjugates as inhibitors of Mycobacterium tuberculosis. Tetrahedron Lett;52:23872389.
  • 3
    Vashishtha V.M. (2009) WHO global tuberculosis control report:Tuberculosis elimination is a distant dream.
  • 4
    Gutierrez-Lugo M.T., Bewley C.A. (2008) Natural products, small molecules, and genetics in tuberculosis drug development. J Med Chem;51:26062612.
  • 5
    Castagnolo D., Radi M., Dessi F., Manetti F., Saddi M., Meleddu R., De Logu A., Botta M. (2009) Synthesis and biological evaluation of new enantiomerically pure azole derivatives as inhibitors of Mycobacterium tuberculosis. Bioorg Med Chem Lett;19:22032205.
  • 6
    Agrawal Y.K., Bhatt H.G., Raval H.G., Oza P.M., Vaidya H.B., Manna K., Gogoi P. (2007) Emerging trends in tuberculosis therapy. J Sci Ind Res;66:191208.
  • 7
    Imaeda T. (1985) Deoxyribonucleic acid relatedness among selected strains of Mycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium bovis BCG, Mycobacterium microti, and Mycobacterium africanum. Int J Syst Bacteriol;35:147150.
  • 8
    Mahairas G.G., Sabo P.J., Hickey M.J., Singh D.C., Stover C.K.J. (1996) Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol;178:12741282.
  • 9
    Nurbo J., Roos A.K., Muthas D., Wahlstrom E., Ericsson D.J., Lundstedt T., Unge T., Karlen A. (2007) Design, synthesis and evaluation of peptide inhibitors of Mycobacterium tuberculosis ribonucleotide reductase. J Pept Sci;13:822832.
  • 10
    Nathan C., Gold B., Lin G., Stegman M., de Carvalho L.P., Vandal O., Venugopal A., Bryk R. (2008) A philosophy of anti-infectives as a guide in the search for new drugs for tuberculosis. Tuberculosis (Edinb);88:S25S33.
  • 11
    Blumberg H.M., Burman W.J., Daley C.L., Etkind S.C., Friedman L.N., Fujiwara P., et al. (2003) American thoracic society/centers for disease control and prevention/infectious diseases society of America: treatment of tuberculosis. Am J Respir Crit Care Med;167:603662.
  • 12
    Weber L. (2002) The application of multi-component reactions in drug discovery. Curr Med Chem;9:12411253.
  • 13
    Schreiber S.L. (2000) Target-oriented and diversity-oriented organic synthesis in drug discovery. Science;287:19641969.
  • 14
    Domling A. (2006) Recent developments in isocyanide based multicomponent reactions in applied chemistry. Chem Rev;106:1789.
  • 15
    Shaabani A., Maleki A., Rezayan A.H., Sarvary A. (2011) Recent progress of isocyanide-based multicomponent reactions in Iran. Mol Divers;15:4168.
  • 16
    Ramaganesh C.K., Yadav D.B., Venkatesh K.B. (2010) Synthesis and biological evaluation of some innovative coumarin derivatives. Int J Chem;49B:11511154.
  • 17
    Sardari S., Mori Y., Horita K., Micetich R.G., Nishibe S., Daneshtalab M. (1999) Synthesis and antifungal activity of coumarins and angular furanocoumarins. Bioorg Med Chem;7:19331940.
  • 18
    Cardoso S.H., Barreto M.B., Lourenço M.C.S., Henriques M.G.M.O., Candéa A.L.P., Kaiser C.R., Souza M.V.N. (2011) Antitubercular activity of new coumarins. Chem Biol Drug Des;77:489493.
  • 19
    Xu Z.Q., Barrow W.W., Suling W.J., Westbrook L., Barrow E., Lin Y.M., Flavin M. (2004) Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis. Bioorg Med Chem;12:11991207.
  • 20
    Shaabani A., Rezayan A.H., Kishipour S., Sarvary A., Ng S.W. (2009) A Novel one-pot three-(in situ five-) component condensation reaction: an Unexpected approach for the synthesis of tetrahydro-2,4-dioxo-1H-benzo[b][1,5]diazepine-3-yl-2-methylpropanamide derivatives. Org Lett;11:33423345.
  • 21
    Shaabani A., Sarvary A., Ghasemi S., Rezayan A.H., Ghadari R., Ng S.W. (2011) An environmentally benign approach for the synthesis of bifunctional sulfonamide-amide compounds via isocyanide-based multicomponent reactions. Green Chem;13:582585.
  • 22
    Shaabani A., Ghadari R., Sarvary A., Rezayan A.H. (2009) Synthesis of highly functionalized bis (4H-chromene) and 4H-benzo[g]chromene derivatives via an isocyanide-based pseudo-five-component reaction. J Org Chem;74:43724374.
  • 23
    Shaabani A., Soleimani E., Rezayan A.H., Sarvary A., Heidary M. (2008) A novel method for the synthesis of substituted 3,4-dihydrocoumarin derivatives via isocyanide-based three-component reaction. Mol Divers;12:197202.
  • 24
    Shaabani A., Soleimani E., Rezayan A.H., Sarvary A., Khavasi H.R. (2008) Novel isocyanide-based four-component reaction: a facile synthesis of fully substituted 3,4-dihydrocoumarin derivatives. Org Lett;10:25812584.
  • 25
    Rezayan A.H. (2012) Stereoselective synthesis of 3,4-dihydro-7-nitrocoumarins via isocyanide-based Multicomponent reaction. C R Chim;15:499503.
  • 26
    Soltani S., Dianat S., Sardari S. (2009) Forward modeling of the coumarin antifungals; SPR/SAR based perspective. Avicenna Journal of Medical Biotechnology;1:95103.
  • 27
    Moradi S., Soltani S., Ansari A.M., Sardari S. (2009) Peptidomimetics and their applications in antifungal drug design. Antiinfect Agents Med Chem;8:118.
  • 28
    Mehravar M., Sardari S. (2011) Screening of antimicrobial membrane-active metabolites of soil microfungi by using chromatic phospholipid/polydiacetylene vesicles. J Mycol Med;21:188197.
  • 29
    Maggi R., Bigi F., Carloni S., Mazzacani A., Sartori G. (2001) Uncatalysed reactions in water: part 2. Preparation of 3-carboxycoumarins. Green Chem;3:173174.